- Home
- NRXP vs AMTX Comparison
NRXP vs AMTX Comparison
Compare NRXP & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | AMTX |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | 29 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 98.6M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | NRXP | AMTX |
|---|---|---|
| Price | $3.30 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $38.25 | $12.00 |
| AVG Volume (30 Days) | 1.2M | ★ 1.8M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.98 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $77,194,000.00 |
| Revenue This Year | $2,547.84 | $49.77 |
| Revenue Next Year | $1,591.73 | $57.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 174.60 |
| 52 Week Low | $1.65 | $1.30 |
| 52 Week High | $3.84 | $3.80 |
Technical Indicators
Market Signals| Indicator | NRXP | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 66.71 | 41.13 |
| Support Level | $1.98 | $2.17 |
| Resistance Level | $3.29 | $2.40 |
| Average True Range (ATR) | 0.20 | 0.31 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 69.08 | 9.39 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.